| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285539 | Parkinsonism & Related Disorders | 2018 | 6 Pages |
Abstract
Carriers of DRD2 risk haplotypes and possibly the BDNF variants rs6265 and DRD3 haplotypes, were at increased risk of dyskinesia, suggesting that these genes may be involved in dyskinesia related pathomechanisms. PD patients with these genetic variants might be prime candidates for treatments aiming to prevent or delay the onset of dyskinesia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Cynthia D.J. Kusters, Kimberly C. Paul, Ilaria Guella, Jeff M. Bronstein, Janet S. Sinsheimer, Matt J. Farrer, Beate R. Ritz,